Payami, B. (2023) “Amiodarone Can Still Be a Drug of Choice at Emergency Departments for Pre-excited Atrial Fibrillation Even in the Face of Guidelines Prohibition”, Journal of Practical Emergency Medicine, 10(1), p. e8. doi: 10.22037/jpem.v10i1.40732.